Hep C - People With Chronic Hepatitis B To Benefit From Guidance On New Drugs

People With Chronic Hepatitis B To Benefit From Guidance On New Drugs
Medical News Today - The National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B. The guidance states that : - - - - Peginterferon alfa-2a is

Vertex Pharmaceuticals
Forbes - Deutsche Bank Securities initiated coverage of Vertex Pharmaceuticals with a "buy' rating and said the development-stage drug company's promising experimental drug candidate VX-950 has "gold standard" potential as a hepatitis C treatment. "Despite a

NDRI researchers evaluate prison Hepatitis program
EurekAlert - In an article published in the Journal of Correctional Health Care, researchers from the National Development and Research Institutes, Inc. (NDRI) reported on an evaluation of an intervention program within a prison system addressing Hepatitis C

VGX Pharmaceuticals and DowpharmaSM Sign Research and Development
WebWire - Blue Bell, PA - February 28, 2006, VGX Pharmaceuticals and DowpharmaSM contract manufacturing services, a business unit of The Dow Chemical Company (NYSE: DOW), today announced they have signed a Research and Development Agreement to advance the